Characterization of in vitro metabolites of cudratricusxanthone A in human liver microsomes. (22nd May 2015)

• Record Type: Journal Article
• Authors: Sim, Juhee; Choi, Eunhwa; Jeong, Gil‐Saeng; Lee, Sangkyu
• Is Part Of: Biopharmaceutics & drug disposition. Volume 36:Number 5(2015:Jul.)
• Page Start: 325
• Page End: 336
• Publication Date: 2015-05-22
• Subjects: Biopharmaceutics -- Periodicals; Drugs -- Metabolism -- Periodicals; Pharmacology -- Periodicals; Biopharmaceutics -- Periodicals; Pharmaceutical Preparations -- metabolism -- Periodicals; 615.19
• DOI: 10.1002/bdd.1943
• Languages: English
• ISSNs: 0142-2782

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <p>Cudratricusxanthone A (CTXA), isolated from the roots of <italic>Cudrania tricuspidata</italic>, exhibits several biological activities; however, metabolic biotransformation was not investigated. Therefore, metabolites of CTXA were investigated and the major metabolic enzymes engaged in human liver microsomes (HLMs) were characterized using liquid chromatography‐tandem mass spectrometry (LC‐MS/MS). CTXA was incubated with HLMs or human recombinant CYPs and UGTs, and analysed by an LC‐MS/MS equipped electrospray ionization (ESI) to qualify and quantify its metabolites. In total, eight metabolites were identified: M1–M4 were identified as mono‐hydroxylated metabolites during Phase I, and M5–M8 were identified as <italic>O</italic>‐glucuronidated metabolites during Phase II in HLMs. Moreover, these metabolite structures and a metabolic pathway were identified by elucidation of MSⁿ fragments and formation by human recombinant enzymes. M1 was formed by CYP2D6, and M2–M4 were generated by CYP1A2 and CYP3A4. M5–M8 were mainly formed by UGT1A1, respectively. While investigating the biotransformation of CTXA, eight metabolites of CTXA were identified by CYPs and UGTs; these data will be valuable for understanding the <italic>in vivo</italic> metabolism of CTXA. Copyright © 2015 John Wiley &amp; Sons, Ltd.</p> </abstract>